150 related articles for article (PubMed ID: 29596463)
21. Inhibin betaB expression in murine adipose tissue and its regulation by leptin, insulin and dexamethasone.
Hoggard N; Cruickshank M; Moar KM; Barrett P; Bashir S; Miller JD
J Mol Endocrinol; 2009 Oct; 43(4):171-7. PubMed ID: 19491194
[TBL] [Abstract][Full Text] [Related]
22. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
23. CTRP7 deletion attenuates obesity-linked glucose intolerance, adipose tissue inflammation, and hepatic stress.
Petersen PS; Lei X; Wolf RM; Rodriguez S; Tan SY; Little HC; Schweitzer MA; Magnuson TH; Steele KE; Wong GW
Am J Physiol Endocrinol Metab; 2017 Apr; 312(4):E309-E325. PubMed ID: 28223291
[TBL] [Abstract][Full Text] [Related]
24. Circadian-clock system in mouse liver affected by insulin resistance.
Yang SC; Tseng HL; Shieh KR
Chronobiol Int; 2013 Jul; 30(6):796-810. PubMed ID: 23738904
[TBL] [Abstract][Full Text] [Related]
25. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
26. Obesity/insulin resistance rather than liver fat increases coagulation factor activities and expression in humans.
Lallukka S; Luukkonen PK; Zhou Y; Isokuortti E; Leivonen M; Juuti A; Hakkarainen A; Orho-Melander M; Lundbom N; Olkkonen VM; Lassila R; Yki-Järvinen H
Thromb Haemost; 2017 Jan; 117(2):286-294. PubMed ID: 27929200
[TBL] [Abstract][Full Text] [Related]
27. Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit.
Hashimoto O; Ushiro Y; Sekiyama K; Yamaguchi O; Yoshioka K; Mutoh K; Hasegawa Y
Biochem Biophys Res Commun; 2006 Mar; 341(2):416-24. PubMed ID: 16426570
[TBL] [Abstract][Full Text] [Related]
28. Blocking high-fat diet-induced obesity, insulin resistance and fatty liver by overexpression of Il-13 gene in mice.
Darkhal P; Gao M; Ma Y; Liu D
Int J Obes (Lond); 2015 Aug; 39(8):1292-9. PubMed ID: 25869601
[TBL] [Abstract][Full Text] [Related]
29. Liver, but not adipose tissue PEDF gene expression is associated with insulin resistance.
Moreno-Navarrete JM; Touskova V; Sabater M; Mraz M; Drapalova J; Ortega F; Serrano M; Catalán V; Gómez-Ambrosi J; Ortiz MR; Pardo G; Pueyo N; Ricart W; Lacinova Z; Haluzik M; Frühbeck G; Fernández-Real JM
Int J Obes (Lond); 2013 Sep; 37(9):1230-7. PubMed ID: 23318725
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues.
Wang H; Knaub LA; Jensen DR; Young Jung D; Hong EG; Ko HJ; Coates AM; Goldberg IJ; de la Houssaye BA; Janssen RC; McCurdy CE; Rahman SM; Soo Choi C; Shulman GI; Kim JK; Friedman JE; Eckel RH
Diabetes; 2009 Jan; 58(1):116-24. PubMed ID: 18952837
[TBL] [Abstract][Full Text] [Related]
31. Lower zinc-alpha2-glycoprotein production by adipose tissue and liver in obese patients unrelated to insulin resistance.
Selva DM; Lecube A; Hernández C; Baena JA; Fort JM; Simó R
J Clin Endocrinol Metab; 2009 Nov; 94(11):4499-507. PubMed ID: 19622624
[TBL] [Abstract][Full Text] [Related]
32. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
[TBL] [Abstract][Full Text] [Related]
33. Molecular therapy for obesity and diabetes based on a long-term increase in hepatic fatty-acid oxidation.
Orellana-Gavaldà JM; Herrero L; Malandrino MI; Pañeda A; Sol Rodríguez-Peña M; Petry H; Asins G; Van Deventer S; Hegardt FG; Serra D
Hepatology; 2011 Mar; 53(3):821-32. PubMed ID: 21319201
[TBL] [Abstract][Full Text] [Related]
34. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
[TBL] [Abstract][Full Text] [Related]
35. The metabolic response to a high-fat diet reveals obesity-prone and -resistant phenotypes in mice with distinct mRNA-seq transcriptome profiles.
Choi JY; McGregor RA; Kwon EY; Kim YJ; Han Y; Park JH; Lee KW; Kim SJ; Kim J; Yun JW; Choi MS
Int J Obes (Lond); 2016 Sep; 40(9):1452-60. PubMed ID: 27146467
[TBL] [Abstract][Full Text] [Related]
36. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
[TBL] [Abstract][Full Text] [Related]
37. Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice.
Adam RC; Pryce DS; Lee JS; Zhao Y; Mintah IJ; Min S; Halasz G; Mastaitis J; Atwal GS; Aykul S; Idone V; Economides AN; Lotta LA; Murphy AJ; Yancopoulos GD; Sleeman MW; Gusarova V
Proc Natl Acad Sci U S A; 2023 Aug; 120(32):e2309967120. PubMed ID: 37523551
[TBL] [Abstract][Full Text] [Related]
38. [Novel strategies that target hepatokines for treatment of type 2 diabetes].
Misu H; Takamura T; Kaneko S
Nihon Rinsho; 2012 Jan; 70(1):157-63. PubMed ID: 22413512
[TBL] [Abstract][Full Text] [Related]
39. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but is not associated with insulin resistance in patients with liver cirrhosis.
Bahr MJ; Boeker KH; Manns MP; Tietge UJ
Clin Endocrinol (Oxf); 2009 Jan; 70(1):60-5. PubMed ID: 18466349
[TBL] [Abstract][Full Text] [Related]
40. Weight gain induced by high-fat feeding involves increased liver oxidative stress.
Milagro FI; Campión J; Martínez JA
Obesity (Silver Spring); 2006 Jul; 14(7):1118-23. PubMed ID: 16899792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
